OX124 is based on Orexo´s world-class drug delivery platform amorphOX® and is designed to reverse the effect of the most powerful synthetic opioids, such as fentanyl Synthetic opioids are behind 91 percent of all fatal opioid overdoses…Original Article
You may also like
Abeona Therapeutics Submits Biologics License...
Basilea Announces FDA Acceptance of New Drug...
Alpha Cognition Announces Submission of New Drug...
FDA Issues Complete Response Letter for PDP-716 NDA...
Basilea Announces Submission of a New Drug Application...
Venatorx Pharmaceuticals Announces FDA Acceptance and...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.